Pfizer, Peloton, Carnival and others

This undated promotional photo, obtained by Reuters on November 16, 2021, shows paxloid, Pfizer’s coronavirus disease (COVID-19) pill, is manufactured in Ascoli, Italy.

Pfizer | Handouts | via Reuters

Pay attention to the companies that hit the headlines at noon.

Pfizer shares jumped 1.9% after UK regulators approved the use of Paxlovid, the drug-maker’s Covid-19 antiviral pill, for people over 18 with mild to moderate illnesses. The FDA last week authorized the use of paxloid for patients 12 years and older with mild to moderate Covid who are likely to end up in hospital or not survive.

Carnival, Norwegian Cruise Line – Cruise line stocks continued to decline after the Centers for Disease Control and Prevention on Thursday said Americans should not cruise, regardless of vaccination status. Carnival was down 2.2%, Norwegian Cruise Line was down 2.3%, and Royal Caribbean shares were also down.

Peloton – Peloton shares fell 2.5% after JMP Securities downgraded the stock to market from its best performing market. JMP said consumer interest in the home fitness company is declining.

Coterra Energy – Oil company fell 2.4% on the last day of 2021. Coterra announced Thursday that VP and CTO Kevin William Smith sold about 40,000 shares earlier this week.

Novavax – Shares in the drug maker fell more than 2% after news of the extension of manufacturing agreements with Korea’s SK bioscience. Novavax has also received emergency use of its Covid-19 vaccines in India.

Didi – The Chinese passenger calling company continued to decline through the end of the year, shedding more than 9% on Friday. Didi went public in June, but the shares have since dropped as Chinese regulators took harsh action against the company.

– Jesse Pound and CNBC’s Yoon Lee provided the coverage.

Source link

Leave a Reply

Your email address will not be published.

Back to top button